A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

Name: A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
License: Public Domain

Jennifer Crombie, MD

ClinicalTrials.gov · Datasets · License: Public Domain

lymphoma, lymphoma, large b-cell, diffuse

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 349946
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.